Insider · CIK 0001756335
Gilde Healthcare U.A. Cooperatieve IV
Files at LVTX (LAVA Therapeutics NV). First filing Oct 10, 2025, latest Oct 20, 2025.
In brief
Gilde Healthcare U.A. Cooperatieve IV files SEC Form 4 as 10% owner at LVTX (LAVA Therapeutics NV). Since Oct 10, 2025, Gilde Healthcare U.A. Cooperatieve IV has reported 0 open-market buys worth $0 and 3 open-market sells worth $5.1M, the latest filed on Oct 20, 2025.
A track record needs three past buys with six months of prices behind them; Gilde Healthcare U.A. Cooperatieve IV has 0, so none is measured yet.
The newest scored trade: sold $4.2M of LVTX on Oct 20, 2015, filed Oct 20, 2025, scored 57 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $4.9M.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | LVTXsell LAVA Therapeutics NV | $4.2M 2,871,370 shares | -97% | - | |
| 33Weak | LVTXsell LAVA Therapeutics NV | $719k 475,027 shares | -9% | - | |
| 24Weak | LVTXsell LAVA Therapeutics NV | $198k 126,992 shares | -2% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -690,239 | $1.49 | $1.0M | 4,128,912 | Oct 20, 2025 |
| Oct 17, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -1,181,131 | $1.47 | $1.7M | 2,947,781 | Oct 20, 2025 |
| Oct 20, 2015 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -1,000,000 | $1.46 | $1.5M | 1,947,781 | Oct 20, 2025 |
| Oct 13, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -47,686 | $1.54 | $73k | 5,246,492 | Oct 15, 2025 |
| Oct 14, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -227,341 | $1.51 | $343k | 5,019,151 | Oct 15, 2025 |
| Oct 15, 2015 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -200,000 | $1.51 | $302k | 4,819,151 | Oct 15, 2025 |
| Oct 8, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -28,954 | $1.57 | $45k | 5,392,216 | Oct 10, 2025 |
| Oct 9, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -48,169 | $1.56 | $75k | 5,344,047 | Oct 10, 2025 |
| Oct 10, 2025 | LVTX LAVA Therapeutics NV | SOpen-market sale Common Shares | -49,869 | $1.55 | $77k | 5,294,178 | Oct 10, 2025 |
Questions about Gilde Healthcare U.A. Cooperatieve IV
Answered from the filings on this page, as of the latest one.
Is Gilde Healthcare U.A. Cooperatieve IV buying or selling?
In the last 12 months Gilde Healthcare U.A. Cooperatieve IV reported 0 open-market buys worth $0 and 2 open-market sells worth $4.9M on SEC Form 4; the latest was sold $4.2M of LVTX on Oct 20, 2015. Grants, option exercises and tax withholding are not counted.
How did Gilde Healthcare U.A. Cooperatieve IV's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gilde Healthcare U.A. Cooperatieve IV has 0.
Where does Gilde Healthcare U.A. Cooperatieve IV file Form 4?
Gilde Healthcare U.A. Cooperatieve IV has filed Form 4 at LVTX (LAVA Therapeutics NV). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.